(
out of
234
reviews
)
Clinical Locations
Primary Location
Huntsman Cancer Institute - Cancer Research North
Clinic 2D/E, BMT/Hematology
2000 Circle of Hope
Salt Lake City
,
UT
84112
Veterans Administration Medical Center
500 S Foothill Blvd
Salt Lake City
,
UT
84148
Board Certification
|
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
American Board of Internal Medicine (Sub: Cardiovascular Disease)
National Board of Echocardiography
|
Patient Rating
Patients consistently describe Dr. Carter as highly knowledgeable and skilled at explaining complex conditions and treatment options in clear, understandable terms. Reviewers highlight his compassion, approachable manner, and willingness to take time to listen, answer questions, and discuss follow-up care. Many report that his clear communication and thorough explanations leave them feeling informed and confident in their care.
Generated via Patient Reviews
4.9
/5
( out of
234 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Assistant Professor (Clinical) |
|---|---|
| Academic Divisions |
Cardiovascular Medicine
|
| Board Certification |
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
American Board of Internal Medicine (Sub: Cardiovascular Disease)
National Board of Echocardiography
|
Education history
| Fellowship | Advanced Heart Failure and Transplant - University of Texas Southwestern Medical School | Fellow |
|---|---|---|
| Fellowship | Cardiology - University of Texas Southwestern Medical School | Fellow |
| Residency | Internal Medicine - University of Texas Southwestern Medical School | Resident |
| Professional Medical | Medicine - University of Washington School of Medicine | M.D. |
| Undergraduate | Science Business - University of Notre Dame | B.S. |
Selected Publications
Journal Article
- Jacobs JA, Greene T, Vanneman ME, Kean J, Carter SJ, Shah KS, Pandey A, Derington CG, Zheutlin AR, Fang J, Stehlik J, Fonarow GC, Bress AP (2026). Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction. JAMA Cardiol, 11(6), 506-514.
- Sideris K, Bunsawat K, Brinker L, Braun E, Iacovelli J, Chen A, Simmons JM, Zhao J, Carter S, Tseliou E, Kyriakopoulos CP, Hanff TC, Florido R, Brann AM, Fang JC, Greene T, Wray DW, Stehlik J (2026). The Effect of Vericiguat on Endothelial Function in Patients with Heart Failure with Reduced Ejection Fraction: A Pilot Randomized Study. Am J Cardiol, 266, 104-111.
- Kyriakopoulos CP, Sideris K, Kyriakoulis I, Taleb I, Maneta E, Zhang C, Tseliou E, Carter S, Florido R, Welt FG, Stehlik J, Selzman CH, Fang JC, Goodwin ML, Tonna JE, Hanff TC, Drakos SG (2026). Factors associated with native heart survival and intermediate-term outcomes in acute myocardial infarction-related cardiogenic shock. Eur Heart J Open, 6(1), oeag015.
- Goodwin A, Goldstein J, Carter SJ (2026). A Rare Case of Obstructive Shock. Circulation, 153(6), 457-462.
- Sideris K, Nelson TJ, Brinker L, Gao A, Tcheandjieu C, Kyriakopoulos CP, Berlowitz D, Hull L, Ferraro JP, Agiri FY, Pridgen KM, Roblin S, Joseph J, Damrauer SM, Chang KM, Teerlink CC, Stehlik J, Carter S, Lynch JA (2025). Systemic Manifestations and Mortality Risk in Transthyretin V142I Variant Carriers: A Million Veteran Program Analysis. JACC CardioOncol, 8(1), 31-44.
- Iacovelli JJ, Alpenglow JK, Stratford Waldron J, Simmons JM, Bunsawat K, Carter SJ, Wray DW (2026). Attenuated Peripheral Vascular Responsiveness Contributes to Baroreflex Dysfunction in Patients with Wild-Type Transthyretin Amyloidosis (wtATTR). Am J Physiol Heart Circ Physiol.
- Sideris K, Nelson TJ, Brinker L, Gao A, Tcheandjieu C, Kyriakopoulos CP, Berlowitz D, Hull L, Ferraro JP, Agiri FY, Pridgen KM, Roblin S, Joseph J, Levin MG, Damrauer SM, Chang KM, Teerlink CC, Stehlik J, Carter S, Lynch JA (2025). Risk of Systemic Manifestations in Homozygous Carriers of the Transthyretin V142I Variant: A Million Veteran Program Analysis. J Am Heart Assoc, 14(23), e044923.
- Carter SJ (2025). Building and Growing a Multi-Disciplinary Program as Early Career Faculty: Lessons Learned and Practical Strategies. J Card Fail.
- Brinker L, Sideris K, Wei G, Singh R, Nevers MR, Hartsell SE, Sarwal A, Kyriakopoulos CP, Tseliou E, Benes J, Melenovsky V, Drakos SG, Hanff TC, Carter S, Fang JC, Cho M, Beddhu S, Stehlik J (2025). Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis. JACC Heart Fail, 13(8), 102520.
- Goldstein J, Stinson L, Sideris K, Waldron J, Mooney R, Barrell K, Godara A, Carter S (2025). Hereditary transthyretin amyloidosis caused by a rare mutation. BMJ Case Rep, 18(7).
- Hutman-Zahler A, Goldstein J, Anderson T, Balatico M, Brophy DR, Aoki J, Miller K, Kovach K, Jacobsen A, Carter S (2025). A Rare Case of Fulminant Myocarditis Leading to the Diagnosis of Systemic Lupus Erythematosus. JACC Case Rep, 30(19), 104049.
- Carter S, Thibodeau JT (2025). Patient Focus: Understanding Muscle Wasting in Heart Failure: An Explanation of Consolidating Concepts from the Recent International Expert Consensus on Sarcopenia: Implications for Heart Failure Management. J Card Fail.
- Le JV, Mendes JK, Sideris K, Bieging E, Carter S, Stehlik J, DiBella EVR, Adluru G (2024). Free-Breathing Ungated Radial Simultaneous Multi-Slice Cardiac T1 Mapping. J Magn Reson Imaging, 61(6), 2587-2600.
- Kyriakopoulos CP, Sideris K, Taleb I, Maneta E, Tseliou E, Aadland J, Baird AS, Bonios MJ, Nelson M, Dranow E, Goodwin ML, Hanff TC, Carter S, Selzman CH, Stehlik J, Wever-Pinzon O, Ramakrishna S, Tumarkin E, Drakos SG (2025). Left Atrial Reverse Remodeling in Patients Supported With Durable Left Ventricular Assist Devices and Clinical Implications. Circ Heart Fail, 18(7), e012807.
- Kim PJ, Olympios M, Sideris K, Tseliou E, Tran TY, Carter S, Brann A, Kaur N, Carey SA, Bhorade S, Chen YA, Barnes D, Ahmed E, Xie J, Prewett A, Rabinowitz M, Zimmermann BG, Bloom MS, Demko Z, Adler E, Stehlik J (2025). A two-threshold algorithm using donor-derived cell-free DNA fraction and quantity to detect acute rejection after heart transplantation. Am J Transplant, 25(9), 1895-1905.
- Sideris K, Zhang M, Wohlfahrt P, Siu AF, Shen J, Carter S, Kyriakopoulos CP, Taleb I, Wever-Pinzon O, Shah K, Selzman CH, Rodriguez-Correa C, Kapelios C, Brinker L, Alharethi R, Hess R, Drakos SG, Steinberg BA, Fang JC, Kfoury AG, Melenovsky V, Greene T, Spertus JA, Stehlik J (2024). Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart Failure. J Card Fail, 31(5), 761-770.
- Scott M, Kyriakopoulos CP, Sheffield E, Krauspe E, Sideris K, Taleb I, Maneta E, Tseliou E, Selko S, Hamouche R, Aadland J, Carter SJ, Jones TL, Ou Z, Presson AP, Selzman CH, Tonna JE, Hanff TC, Drakos SG (2025). Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Centre Analysis. Can J Cardiol, 41(10), 2053-2063.
- Carter S, Thibodeau JT (2024). Patient Focus: Rates of Heart Failure Medicines and Hospital Readmission: An explanation of "Prescription Patterns in the Management of Heart Failure and its Association with Readmissions: A Retrospective Analysis". J Card Fail, 31(4), 646-647.
- Bullock G, Jacobs JA, Carey JR, Pan IZ, Kinsey MS, Sideris K, Kapelios CJ, Stehlik J, Fang JC, Das S, Carter SJ (2024). Patterns of diuretic titration during inpatient management of acute decompensated heart failure. Am Heart J, 282, 30-39.
- Kyriakopoulos CP, Taleb I, Sideris K, Maneta E, Hamouche R, Tseliou E, Krauspe E, Selko S, Carter S, Jones TL, Zhang C, Presson AP, Dranow E, Geer L, Stehlik J, Selzman CH, Goodwin ML, Tonna JE, Hanff TC, Drakos SG (2025). Informing Management of Patients Developing Cardiogenic Shock at a Spoke and Being Transferred to a Hub. J Am Heart Assoc, 14(4), e035464.
- Bozkurt B, Ahmad T, Alexander K, Baker WL, Bosak K, Breathett K, Carter S, Drazner MH, Dunlay SM, Fonarow GC, Greene SJ, Heidenreich P, Ho JE, Hsich E, Ibrahim NE, Jones LM, Khan SS, Khazanie P, Koelling T, Lee CS, Morris AA, Page RL 2nd, Pandey A, Piano MR, Sandhu AT, Stehlik J, Stevenson LW, Teerlink J, Vest AR, Yancy C, Ziaeian B, WRITING COMMITTEE MEMBERS (2024). HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America. J Card Fail, 31(1), 66-116.
- Carter S, Thibodeau JT (2024). Patient Focus: Moving Beyond Step Count: An Explanation of Real-World Walking Behaviors Are Associated With Early-Stage Heart Failure: A Project Baseline Health Study. J Card Fail, 30(11), 1437-1438.
- Taleb I, Giannouchos TV, Kyriakopoulos CP, Clawson A, Davis ES, Sideris K, Tseliou E, Shah KS, Tonna JE, Dranow E, Jones TL, Carter SJ, Fang JC, Stehlik J, Ohsfeldt RL, Selzman CH, Hanff TC, Drakos SG (2024). Cost-Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock. Circ Heart Fail, 17(11), e011709.
- Jacobs JA, Carter SJ, Bullock G, Carey JR, Pan IZ, Kinsey MS, Zheutlin AR, Kapelios CJ, Raju S, Fang JC, Shah KS, Bress AP (2024). Optimal Initial Intravenous Loop Diuretic Dosing in Acute Decompensated Heart Failure. JACC Adv, 3(10), 101250.
- ONeill E, Carter S, Brann A, Ibrahim M, Shah KS (2024). Anomalous Coronary Artery Identified Post Heart Transplantation. JACC Case Rep, 29(15), 102442.
- Stehlik B, Sideris K, Brinker L, Waldron J, Carter S (2024). Wild-Type Transthyretin Amyloidosis: A Prevalent and Underdiagnosed Cause of Heart Failure With Preserved Ejection Fraction. Cureus, 16(6), e62623.
- Carter S, Thibodeau JT (2023). Patient Focus: When Should People With Heart Failure Who Were Admitted to the Hospital Think About Palliative or Hospice Care? An Explanation of "Factors Associated with Mortality and Hospice Use Among Medicare Beneficiaries With Heart Failure Who Received Home Health Services". J Card Fail, 30(6), 803-804.
- Hart Z, Anderson T, Fanous H, Liori S, Carter S (2024). A Case of Stress-Induced Cardiomyopathy After Ketamine Infusion. Cureus, 16(5), e59709.
- Stern LK, Grodin JL, Maurer MS, Ruberg FL, Patel AR, Khouri MG, Roth LR, Aras MA, Bhardwaj A, Bhattacharya P, Brailovsky Y, Drachman BM, Ebong IA, Fine NM, Gaggin H, Gopal D, Griffin J, Judge D, Kim P, Mitchell J, Mitter SS, Mohan RC, Ramos H, Reyentovich A, Sheikh FH, Sperry B, Carter S, Urey M, Vaishnav J, Vest AR, Kittleson MM, Patel JK (2023). The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology. J Card Fail, 30(5), 669-678.
- Balakrishnan N, Beaini H, Carter S, Araj FG (2024). Bedside popliteal vein cannulation for simultaneous plasmapheresis and renal replacement therapy in the prone position. J Invasive Cardiol, 36(5).
- Sideris K, Lzr-Molnr E, Kyriakopoulos CP, Taleb I, Hurst D, Ugolini S, Selzman CH, Brinker L, Drakos SG, Tonna JE, Geer L, Goodwin ML, Wever-Pinzon O, Hanff TC, Fang JC, Carter S, Stehlik J (2024). Bridge-to-transplant temporary mechanical circulatory support and risk of allosensitization. Clin Transplant, 38(5), e15330.
- Hendren NS, Carter S, Rao A, La Hoz RM, Cutrell JB, Fares M, Concejo B, de Lemos JA, Drazner MH, Zaha VG, Grodin JL (2023). Convalescent Phenotyping of Cardiac Injury During Hospitalization for Acute COVID-19. Am J Cardiol, 209, 199-202.
- Omar W, Hendren NS, Carter S, Mathew C, Alvarez KS, Bhavan K, Joglar J, Das SR (2023). Home Inotrope Program for Self-Funded Patients in a Safety-Net Hospital System (A Pilot Experience). Am J Cardiol, 197, 1-2.
- Hendren NS, de Lemos JA, Ayers C, Das SR, Rao A, Carter S, Rosenblatt A, Walchok J, Omar W, Khera R, Hegde AA, Drazner MH, Neeland IJ, Grodin JL (2020). Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation, 143(2), 135-144.
- Bennett AJ, Carter S, Joglar JA (2019). A New Tachyarrhythmia in a 60-Year-Old Woman. Circulation, 140(11), 965-968.
- Grodin JL, Carter S, Bart BA, Goldsmith SR, Drazner MH, Tang WHW (2018). Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Eur J Heart Fail, 20(7), 1148-1156.
Review
- Raven LM, Brinker L, Sideris K, Muir CA, Carter S, Beddhu S, Macdonald PS, Stehlik J (2025). Sodium glucose cotransporter 2 inhibitor use after heart transplant: Current knowledge and potential applications. [Review]. Am J Transplant.
- Sideris K, Kyriakopoulos CP, Brinker L, Taleb I, Liori S, Hutman-Zahler A, Hendren N, Hall E, Drakos SG, Stehlik J, Fang JC, Drazner MH, Carter S (2025). Advanced Markers for Hemodynamic Monitoring in Cardiogenic Shock and End-Stage Heart Failure: A Mini Review. [Review]. Heart Fail Rev, 30(3), 529-535.
- Huang AL, Hendren N, Carter S, Larsen C, Garg S, La Hoz R, Farr M (2022). Biomarker-Based Assessment for Infectious Risk Before and After Heart Transplantation. [Review]. Curr Heart Fail Rep, 19(4), 236-246.
- Vasquez N, Carter S, Grodin JL (2020). Angiotensin Receptor-Neprilysin Inhibitors and the Natriuretic Peptide Axis. [Review]. Curr Heart Fail Rep, 17(3), 67-76.
Editorial
- Carter S, Fang JC (2024). Waiting for Godot?: REDUCE LAP HF-II at 24 Months. JACC Heart Fail, 12(8), 1439-1441.
- Carter S, Hendren NS, Grodin JL (2022). Sodium-glucose cotransporter 2 inhibition, uric acid, and heart failure: correlation without causation? Eur J Heart Fail, 24(6), 1077-1079.
- Hendren NS, Carter S, Grodin JL (2021). Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn? Int J Cardiol, 343, 197-198.
Letter
- Neela N, Hendren NS, Carter S, Hernandez L, Truby LK, Farr M, DAS SR (2024). Contraception Counseling and Teratogenic Prescriptions Among Women With Systolic Heart Failure in a Safety-Net Health System. [Letter to the editor]. J Card Fail, 30(11), 1527-1529.
- Gulati J, Yen C, Almonte M, Shah P, Carter S, Godfrey S, Bhatt A (2024). Implementation of a Resident-Led Cardiac Point-of-Care Ultrasound Curriculum for the Internal Medicine Residency Program at the University of Texas Southwestern. [Letter to the editor]. J Am Soc Echocardiogr, 37(7), 720-721.
- Almonte M, Shah P, Berlacher M, Carter S, Raygor V, Bhatt A (2022). Online and Simulation-Based Cardiac Point-of-Care Ultrasound Training for Residents: A Randomized Pilot Study. [Letter to the editor]. J Am Soc Echocardiogr, 35(8), 889-890.
Thank You Dr Carter
I thought he was very honest. [TRANSLATED]
Dr. Carter is very helpful & concerned about the concerns I brought to him. He offered some solutions to see if it would help with my symptoms. He was very willing to follow up after I have tried the suggestions he gave me.
He is extremely knowledgeable and explains even complex medical issues simply and clearly. He takes all the time you need to understand and, he has a winning sense of humor. Fabulous physician and person.
Dr. Carter is very good in explaining my disease and the treatment protocol even though it is a quite daunting he talked about the successes, the lack of side affects as well as the care to be taken in following procedures at home
Very friendly, knowledgeable. Explained scan results so I could understand.
Very good doctor. Informative and understanding.
Dr. Carter is intelligent and I'm sure knows his stuff. However, I feel he wasn't prepared for my first appointment. He didn't mention the lab results that he had prescribed, and he hadn't studied or collected all of my prior records. I just left feeling that he wanted me to doubt my previous Dr.¿s and diagnosis.
Dr Carter explains everything in detail and is very helpful in listening to questions.
Dr. Carter is amazing. He is very wise and very caring. I am lucky he is my doctor
My initial thoughts of Dr Carter are that he is an excellent doctor and while explaining my condition Dr Carter was patient, prepared, sympathetic to my needs. I believe I am in good hands and am hoping to be enrolled in pertinent trials.
Dr. Carter explained the condition and his diagnosis carefully and understandably. Treatment will be determined when diagnosis is confirmed!
Extremely personal, down to earth, willing to answer all questions, compassionate. So much information was given that I couldn't absorb everything but Dr. Carter advised websites so I can follow up. Never felt that he was in a hurry. Absolutely the best I could have asked for (for a serious issue, amyloidosis) that was being addressed)
Dr. Spencer Carter was very professional and courteous. He Reviewed my history and treatment and provided the latest and future options of treatments. He had clear explanations and provided time and answers for questions. Great visit and can highly recommend him.
Knowledgeable, caring, takes a very personal interest in me as the patient an human being.
I really appreciated his preparation for the new patient visit, and his true passion and depth of knowledge and understanding for everything Amylosis. He took the time during the visit to make sure I felt that my concerns were heard, communicated, and fully understood. I have great confidence that he will continue to follow through to arrange for the specific proper care that I need. Thank you so much!
I was very impressed with Dr Carter. He took the time to explain things to me in a way that I understand everything.
I can't recommend Dr. Carter highly enough. He is caring, knowledgeable, and just a brilliant physician.
His experience about amyloidosis is far reaching and i trust his judgement
I felt like I had a knowledgeable dr who could give me the correct diagnosis and answer my questions
Dr Carter explained a very complex situation in an underandable way. He used my test results as well as research data to make an argument for his decision regarding my treatment. He also worked well with his fellow to deliver this information. He presented the news about my condition in a compassionate way ans he was interested in my thoughts ans concerns.
Thank you
So wonderful to meet with a Doctor who understands my illness and could explain what I am facing and help me set realistic goals. Cheers
Dr. Carter is a true professional.
We would highly recommend Dr. Carter. He was very compassionate and down to earth in his explanations.